BioCardia, Inc. Debt Conversion, Converted Instrument, Amount
BioCardia, Inc. (BCDA) reported Debt Conversion, Converted Instrument, Amount of $633.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2021-03-30
- BioCardia, Inc. debt conversion, converted instrument, amount for the quarter ending 2019-12-31 was $0.00.
- BioCardia, Inc. debt conversion, converted instrument, amount for fiscal 2019 was $633.00K.
- BioCardia, Inc. debt conversion, converted instrument, amount for fiscal 2016 was $12.16M, a 56.23% increase from fiscal 2015.
- BioCardia, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $7.78M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 9 month as first filed | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $633.00K 10-K · filed 2021-03-30 | ||
| 2019-09-30 | $633.00K 10-Q · filed 2020-11-10 | $8.00K 10-Q · filed 2019-11-19 | ||
| 2016-12-31 | $12.16M 10-K · filed 2019-04-02 | |||
| 2015-12-31 | $7.78M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |